Medicine composition and preparing method
A technology of composition and medicine, which is applied in the field of pharmaceutical composition and its preparation, can solve the problems of uncertain curative effect, incomplete understanding of mechanism, and the advent of empirical Chinese medicine preparations for depression, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
experiment example 1
[0036] Experimental example 1. the influence of capsule of the present invention on mouse tail suspension
[0037] group
dosage
number of animals
Immobility time (s)
control group
Clomipramine group
Capsules of the present invention
20mg / kg
0.3g / kg
0.6g / kg
1.2g / kg
13
12
12
10
10
103.92±53.78
40.83±43.89**
79.08±50.77
57.80±35.29*
42.40±47.62**
[0038] *P<0.05, **P<0.01 compared with the control group
[0039] The results in Table 1 show that both the high and medium dose groups of the capsules of the present invention can significantly shorten the tail suspension time of mice, and the difference is significant compared with the blank group (P<0.01, P<0.05).
experiment example 2
[0040] Experimental example 2. the influence of capsule of the present invention on mice's forced swimming
[0041] group
dosage
number of animals
Immobility time (s)
control group
Clomipramine group
Capsules of the present invention
20mg / kg
0.3g / kg
0.6g / kg
1.2g / kg
15
13
13
13
11
108.06±41.05
58.84±28.72**
90.46±40.78
73.00±35.80*
68.63±38.24**
[0042] *P<0.05, **P<0.01compared with control compared with control group
[0043] The results in Table 2 show that both the high and middle dose groups of the capsules of the present invention can significantly shorten the immobility time of mice forced to swim, and the difference is significant compared with the blank group (P<0.01, P<0.05).
experiment example 3
[0044] Experimental Example 3. Effects of Capsules of the Present Invention on Reserpine-induced Mouse Body Temperature Drop
[0045] group
Dose (g / kg)
Number of animals (n)
body temperature (°C)
Blank control group
Reserpine group
Anafranil group
Capsules of the present invention
0.0016
0.02
0.3
0.6
1.2
10
10
9
10
9
10
37.86±0.622)
35.70±0.60
36.66±0.712)
36.12±0.55
36.56±1.031)
36.94±0.862)
[0046] *P<0.05, **P<0.01 compared with the control group
[0047] The results in Table 3 show that the high and middle dose groups of the capsules of the present invention can significantly resist the drop in body temperature of mice caused by reserpine, and the difference is significant compared with the blank group (P<0.01, P<0.05).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com